Ascendis Pharma A/S
ASND · NASDAQ
$243.37+$0.38 (+0.16%)TodayMarket closed ·
Prev close $242.99
Who owns ASND
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 63.5% of ASND’s shares.
- RA Capital Management, LP15.5%
- T. Rowe Price Investment Management, Inc.10.2%
- Avoro Capital Advisors LLC7.7%
- Westfield Capital Management Company, L.P.7.2%
- Next 6 largest institutions22.9%
- All other shareholders36.5%
| Holder | Shares | % of shares |
|---|---|---|
| RA Capital Management, LP | 10.28M | 15.48% |
| T. Rowe Price Investment Management, Inc. | 6.75M | 10.17% |
| Avoro Capital Advisors LLC | 5.11M | 7.70% |
| Westfield Capital Management Company, L.P. | 4.80M | 7.23% |
| Janus Henderson Investors | 3.65M | 5.50% |
| Fidelity Management & Research Company LLC | 3.24M | 4.88% |
| Artisan Partners Limited Partnership | 2.63M | 3.97% |
| Capital International Investors | 1.99M | 2.99% |
| MFS Investment Management | 1.87M | 2.82% |
| BlackRock Institutional Trust Company, N.A. | 1.85M | 2.78% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| T. Rowe Price Capital Appreciation Fund | 3.36M | 5.07% |
| MFS Mid Cap Growth Fund | 1.27M | 1.92% |
| American Funds Growth Fund of America | 1.21M | 1.82% |
| Vanguard Health Care Fund | 1.02M | 1.54% |
| Franklin DynaTech Fund | 1.00M | 1.51% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $777.07K (9 trades) and sold $5.51M (3 trades) of ASND on the open market.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Bodenhoff Mads | Option exercise | 3.00K | — |
| Bodenhoff Mads | Sale | 3.00K | $810.57K |
| Bodenhoff Mads | Option exercise | 3.00K | $330.00K |
| HOLTUG LARS | Sale | 236 | $62.33K |
| BIENAIME JEAN JACQUES | Buy | 900 | $222.22K |
| BIENAIME JEAN JACQUES | Buy | 1.10K | $270.44K |
| SMITH SCOTT THOMAS | Buy | 100 | $21.90K |
| SMITH SCOTT THOMAS | Buy | 250 | $55.83K |
| BIENAIME JEAN JACQUES | Buy | 100 | $22.35K |
| BIENAIME JEAN JACQUES | Buy | 200 | $44.46K |
Short interest
Settled Sep 30, 2026
- Shares short
- 3.48M
- Days to cover
- 3.72
- % of shares outstanding
- 5.25%
- Average daily volume
- 937.17K
- Change since last report
- −12.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.